Ironvine Capital Partners’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-7,068
Closed -$1.36M 57
2021
Q1
$1.36M Hold
7,068
0.16% 53
2020
Q4
$1.43M Hold
7,068
0.18% 51
2020
Q3
$1.49M Hold
7,068
0.19% 49
2020
Q2
$1.55M Hold
7,068
0.21% 45
2020
Q1
$1.23M Sell
7,068
-2,764
-28% -$457K 0.19% 47
2019
Q4
$1.51M Hold
9,832
0.18% 59
2019
Q3
$1.47M Hold
9,832
0.22% 46
2019
Q2
$1.61M Hold
9,832
0.26% 45
2019
Q1
$1.58M Hold
9,832
0.3% 46
2018
Q4
$1.44M Hold
9,832
0.29% 44
2018
Q3
$1.48M Hold
9,832
0.3% 48
2018
Q2
$1.33M Buy
9,832
+3,617
+58% +$446K 0.3% 51
2018
Q1
$827K Hold
6,215
0.2% 62
2017
Q4
$924K Buy
+6,215
New +$846K 0.29% 60

Other funds holding CLX

Ironvine Capital Partners's CLX Position: Q2 2021 in Review

Ironvine Capital Partners sold out of Clorox (CLX) in Q2 2021, closing a stake of 7,068 shares — an estimated $1.36M sold.

Ironvine Capital Partners first reported a position in CLX in Q4 2017 and held it in 14 quarters. The position peaked at $1.61M in Q2 2019. 1,170 funds tracked by Wall St. Rank hold CLX as of Q2 2021.

  • Ironvine Capital Partners reported no remaining Clorox position as of Q2 2021 after selling out during the quarter.
  • Ironvine Capital Partners sold 7,068 Clorox shares in Q2 2021, an estimated $1.36M.
  • Ironvine Capital Partners first reported a position in Clorox in Q4 2017 and held it in 14 quarters.
  • Ironvine Capital Partners's Clorox position peaked at $1.61M in Q2 2019.
  • 1,170 funds tracked by Wall St. Rank held Clorox as of Q2 2021.

Based on Ironvine Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.